This Article Full Text Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Delva, P. T. Articles by Lechi, A. Search for Related Content PubMed PubMed Citation Articles by Delva, P. T. Articles by Lechi, A.

(Hypertension. 1996;28:433-439.)
© 1996 American Heart Association, Inc.

Articles

Intralymphocyte Free Magnesium in a Group of Subjects With Essential Hypertension

Pietro T. Delva; Caterina Pastori; Maurizio Degan; Germana D. Montesi; Alessandro Lechi

the Institute of Internal Medicine, University of Verona (Italy).

Correspondence to Dr Pietro Delva, Medicina Interna C, Universita di Verona, Policlinico Borgo Roma, 37134 Verona, Italy.

Despite the importance of magnesium in essential hypertension, few data are available on the ionized intracellular concentration of this ion. We therefore studied intralymphocyte free intracellular magnesium (Mg_i) in 32 untreated essential hypertensive subjects and 27 normotensive control subjects by means of a fluorimetric technique based on the use of the new magnesium-sensitive dye furaptra. We also measured intralymphocyte ionized calcium (Ca_i) with fura 2. No statistically significant differences were found in Mg_i in hypertensive compared with normotensive subjects (essential hypertensive, 0.291±0.053 mmol/L; normotensive, 0.293±0.043 [mean±SD]). A statistically significant inverse correlation was established between Mg_i and plasma triglycerides in essential hypertensive subjects (r=-.521, P=.002). The hypertensive group was arbitrarily divided into two subgroups according to plasma triglyceride levels (>2 [n=10] or <2 mmol/L [n=22]), and Mg_i proved to be significantly lower in the subgroup with high plasma triglyceride levels compared with either the subgroup with normal triglycerides (P=.009; 95% confidence interval, 0.013-0.088) or the normotensive control group as a whole (P=.03; 95% confidence interval, 0.003-0.069) (high-triglyceride hypertensive subgroup, Mg_i=0.256±0.045 mmol/L; normal-triglyceride hypertensive subgroup, Mg_i=0.307±0.049). No statistically significant differences were found in Ca_i in hypertensive compared with normotensive subjects (hypertensive, 53±12 nmol/L; normotensive, 54±14). We did not find statistically significant correlations between Ca_i and plasma triglycerides, nor did we find any differences in Ca_i between the subgroup of hypertensive subjects with high plasma triglyceride levels and either the subgroup of hypertensive subjects with normal triglycerides or the normotensive control group as a whole. The discrepancies between our results in lymphocytes and data relating to either erythrocytes or platelets emphasize the need for caution before the results are extrapolated from one tissue to the other. The decreased Mg_i levels in the subgroup of high-triglyceride hypertensive subjects may suggest a role for magnesium in plurimetabolic syndrome.

Key Words: magnesium • calcium • lymphocytes • hypertension, arterial • triglycerides

This article has been cited by other articles:

				P Delva, M Degan, M Trettene, and A Lechi Insulin and glucose mediate opposite intracellular ionized magnesium variations in human lymphocytes. J. Endocrinol., September 1, 2006; 190(3): 711 - 718. [Abstract] [Full Text] [PDF]

				P. Delva, C. Pastori, M. Degan, G. Montesi, P. Brazzarola, and A. Lechi Intralymphocyte Free Magnesium in Patients With Primary Aldosteronism : Aldosterone and Lymphocyte Magnesium Homeostasis Hypertension, January 1, 2000; 35(1): 113 - 117. [Abstract] [Full Text] [PDF]